Insider and Institutional Ownership
24.5% of PetVivo shares are owned by institutional investors. Comparatively, 3.3% of Assure shares are owned by institutional investors. 10.8% of PetVivo shares are owned by company insiders. Comparatively, 3.8% of Assure shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Risk and Volatility
PetVivo has a beta of 1.14, indicating that its stock price is 14% more volatile than the S&P 500. Comparatively, Assure has a beta of 217.15, indicating that its stock price is 21,615% more volatile than the S&P 500.
Valuation & Earnings
This table compares PetVivo and Assure”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| PetVivo | $1.05 million | 37.60 | -$10.95 million | ($0.40) | -2.90 |
| Assure | $250,000.00 | 0.01 | -$26.08 million | ($56.12) | 0.00 |
PetVivo has higher revenue and earnings than Assure. PetVivo is trading at a lower price-to-earnings ratio than Assure, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares PetVivo and Assure’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| PetVivo | -902.82% | -4,813.07% | -281.78% |
| Assure | N/A | N/A | N/A |
Summary
PetVivo beats Assure on 6 of the 11 factors compared between the two stocks.
About PetVivo
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.
About Assure
Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services in the United States. It offers services in the areas of neurosurgery, spine, cardiovascular, orthopedic, ear, nose, throat, and other surgical procedures. The company delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures. Assure Holdings Corp. is based in Englewood, Colorado.
Receive News & Ratings for PetVivo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetVivo and related companies with MarketBeat.com's FREE daily email newsletter.
